chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Treatment of COVID-19; Treatment of COVID-19; Vaccine brand=Pfizer / BioNTech/ vaccine brand other=Moderna; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 5 (booster), single (Lot number: GJ665) at the age of 68 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 14Apr2022 as dose 4 (booster), single (Lot number: 005M21A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 11Oct2022, outcome "unknown", described as "Vaccine brand=Pfizer / BioNTech/ vaccine brand other=Moderna"; COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19, drug ineffective. Clinical course: The patient had No known allergies. He received Paxlovid for COVID-19 treatment from 07Jan2023 to 12Jan2023.
90 days post vaccine and almost to the day broke out in shingles on the same side of my face as the arm I was given the vaccine reported healthy and next day got shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (90 days post vaccine and almost to the day broke out in shingles on the same side of my face as the arm I was given the vaccine reported healthy and next day got shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (90 days post vaccine and almost to the day broke out in shingles on the same side of my face as the arm I was given the vaccine reported healthy and next day got shingles). At the time of the report, HERPES ZOSTER (90 days post vaccine and almost to the day broke out in shingles on the same side of my face as the arm I was given the vaccine reported healthy and next day got shingles) outcome was unknown.            Treatment medication not provided.  Concomitant medication not provided.
medication leaked out, received maybe 0.1 ml; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a adult male patient who received Herpes zoster (Shingrix) (batch number 4XA55, expiry date 13th July 2023) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown.   Additional Information: GSK Receipt Date: 13-JUN-2022 Reporter's Comment: The reporter reported that, while administering the Shingrix vaccine, most of the medication leaked out.  The patient might be received 0.1 ml of the Shingrix.  No reactions were reported. The reporter consented to follow up via email. Additional Supportive Information: While administering the Shingrix vaccine, most of the medication leaked out and the patient received might be 0.1 ml of the Shingrix, which led to accidental underdose.
Painful at site red & warm for one day after injection. Did not see MD. Gone the next day.
N INSTED OF 6M-4YR PFIZER. MA PREPPED 5-11YR PFIZER AND LABELED AS 6M-4Y PFIZER. NURSE ADMINISTERED AND WHEN SHE WENT TO DOCUMENT THE VACCINE WAS UNAVAILABLE. MA DOUBLE CHECKED STOCK AND NOTICED PFIZER 6M-4YR WAS UNAVAILABLE
swelling, warmth, pain/soreness and itchiness since vaccine was administered at left upper arm
Patient had aches and pains and one episode of vomiting the evening of having the Fluzone HD vaccine administered.
Information has been received from a certified medical assistant concerning a male patient who in August 2006, was vaccinated with a 0.5 ml dose of Pneumovax 23 (lot# 651356/0089F). In August 2006, the patient experienced redness, soreness and swelling at the injection site. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. A lot check was requested. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Initial report received from a healthcare professional on 02 October 2012. A male patient of unspecified demographics, who had no illness at the time of vaccination and with unknown medical history, had received a dose of FLUZONE (Lot number, dose number and anatomical site of vaccination not reported) intramuscularly on 20 August 2012. On 21 August 2012, the patient had flu like symptoms and had chills that seemed like convulsions every 3 hours, no temperature was taken. The patient reported that he had a difficult night from exactly 12 am to 6 am on 21 August 2012. The patient did not seek medical attention from a physician; go to the hospital or ED. Laboratory details were none and corrective treatment was not reported. As of 02 October 2012, the patient had recovered from the events. Documents held by sender: none.
1305:1st dose Pfizer vaccine administered (client is an employee at facility).  1410: client no longer under observation, but is in breakroom at facility and reports feeling dizzy and having a headache. (he said it started after vaccination but did not report it at that time). He just finished a fried food lunch and is drinking soda. pulse 2+. 91bpm. Sp02 97%. RR 18. Client is a large man and the BP cuff did not fit appropriately. Taken on upper L arm 162/112. Client denies history of hypertension. Client reports feeling hot. Ice pack applied to neck  1413: BP taken on R foream 158/108 1418: BP taken on L forearm 142/100. Patient instructed to follow up with primary healthcare provider for hypertension or any further symptoms. Did not want to seek emergent care. Educated that headache/ dizziness are both symptoms of high blood pressure. Also instructed on the dangers of high blood pressure.  HR 92
Headache (6-7 days) , loss of strength (still on going) , couldn't get out of. bed for 3-4 days.
Nausea, vomiting, body aches, headache, fever, chills, pain, felt worse than when I had covid.
14 dead relatives and friends that took that; This case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unknown cause of death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the unknown cause of death was fatal. The reported cause of death was unknown cause of death.   It was unknown if the reporter considered the unknown cause of death to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 7-Jul-2022 Reporter's Comments: This case was reported by a patient's relative or friend via interactive digital media. The reporter reported that she/he had 14 dead relatives and friends that took that crap poison (Shingles vaccine). Additional Supportive Information:  The follow-up would not possible as no contact details were available. This case is 1 of 16 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR104784:Same reporter US-GLAXOSMITHKLINE-US2022AMR104786:Same reporter US-GLAXOSMITHKLINE-US2022AMR104789:Same reporter US-GLAXOSMITHKLINE-US2022AMR104794:Same reporter US-GLAXOSMITHKLINE-US2022AMR104773:Same reporter US-GLAXOSMITHKLINE-US2022AMR104785:Same reporter US-GLAXOSMITHKLINE-US2022AMR104782:Same reporter US-GLAXOSMITHKLINE-US2022AMR104795:Same reporter US-GLAXOSMITHKLINE-US2022AMR104793:Same reporter US-GLAXOSMITHKLINE-US2022AMR104787:Same reporter US-GLAXOSMITHKLINE-US2022AMR104797:Same reporter US-GLAXOSMITHKLINE-US2022AMR104799:Same reporter US-GLAXOSMITHKLINE-US2022AMR104801:Same reporter US-GLAXOSMITHKLINE-US2022AMR104876:Same reporter US-GLAXOSMITHKLINE-US2022AMR104854:Same reporter; Reported Cause(s) of Death: Unknown cause of death
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with ZOSTAVAX. Two week after the patient received the vaccine developed chickenpox. On an unspecified date, the patient recovered from symptoms of chickenpox. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
The RN observation prior to administering the vaccine was that the patient appeared very anxious.  The patient stated that he was afraid of needles.  The J&J vaccine was administered.  He immediately stated that he was not okay.  Patient was emotional.  Stated ?I don?t feel well?.  Blurry vision.  Diaphoretic.  Patient instructed to lay on the floor, legs were elevated, cold packs to forehead and back of his neck.  Bottle water provided.  BP-178/100, HR-98, 02 ? 99% .  EMS initiated.  Vitals eventually decreased to BP-142/84 and 02-97%.  Patient never lost consciousness.  Patient assessed by EMS.  Patient denied to be transported to the ER.  Patent assessed by EMS and Vaccine staff for approx 45 minutes.  Patient left in stable condition.
Extreme virtigo. The virtigo is constant anddoesnt change if I sit, stand, or laydown.; Migraine; Stomach sickness; So dizzy cant function; Period 3 times in the last 5 weeks; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic daily migraines and ovarian cysts. Concomitant medications included mirtazapine (REMERON) 30 mg once daily and buprenorphine hydrochloride (SUBTEX) 2mg sublingual tablets twice daily; both from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 15Mar2021 at 12:45 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. The patient previously took tramadol hydrochloride (ULTRAM) and codeine (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 15:00, the patient experienced extreme virtigo for over 1 week which caused a migraine and stomach sickness, so dizzy can't function. The virtigo is constant and doesn't change if the patient sit, stand or lay down. The patient also had period 3 times in the last 5 week. It was reported that the patient had no side effects after the first dose. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with antivert and zofran. The clinical outcome of the events extreme virtigo, the virtigo is constant and doesn't change if I sit, stand, or lay down, migraine, stomach sickness, dizzy can't function and period 3 times in the last 5 week were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
SOME MILD SYMPTOMS; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced mild symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild symptoms was not reported. This report was non-serious. This case, from the same reporter is linked to 20211245092.
Sore but not painful; Had red rash, started from the injection site and move it to the top of his arm; Red rash, started form the injection site and move it to the top of his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore but not painful), VACCINATION SITE RASH (Had red rash, started from the injection site and move it to the top of his arm) and VACCINATION SITE ERYTHEMA (Red rash, started form the injection site and move it to the top of his arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore but not painful), VACCINATION SITE RASH (Had red rash, started from the injection site and move it to the top of his arm) and VACCINATION SITE ERYTHEMA (Red rash, started form the injection site and move it to the top of his arm). At the time of the report, PAIN IN EXTREMITY (Sore but not painful), VACCINATION SITE RASH (Had red rash, started from the injection site and move it to the top of his arm) and VACCINATION SITE ERYTHEMA (Red rash, started form the injection site and move it to the top of his arm) outcome was unknown.            Concomitant medications were not reported.  Treatment information in response to events was not provided.
The patient noticed that he lost a lot of strength in his left arm,  Had trouble performing tasks like opening a bottle of water; pain in left shoulder, This pain then extended to his left elbow and left forearm; pain on his left side from right above the beltline of his waist; The patient received his second Moderna Covid-19 vaccine on 6APR2021. The patientexperienced a sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (The patient noticed that he lost a lot of strength in his left arm,  Had trouble performing tasks like opening a bottle of water) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Spinal fusion NOS (Cervical infusion on Lumbar 3 and 4 from 2008) in 2008.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (The patient received his second Moderna Covid-19 vaccine on 6APR2021. The patientexperienced a sore left injection site arm). In June 2021, the patient experienced BACK PAIN (pain on his left side from right above the beltline of his waist). On an unknown date, the patient experienced ASTHENIA (The patient noticed that he lost a lot of strength in his left arm,  Had trouble performing tasks like opening a bottle of water) (seriousness criterion medically significant) and ARTHRALGIA (pain in left shoulder, This pain then extended to his left elbow and left forearm). At the time of the report, ASTHENIA (The patient noticed that he lost a lot of strength in his left arm,  Had trouble performing tasks like opening a bottle of water), BACK PAIN (pain on his left side from right above the beltline of his waist), ARTHRALGIA (pain in left shoulder, This pain then extended to his left elbow and left forearm) and VACCINATION SITE PAIN (The patient received his second Moderna Covid-19 vaccine on 6APR2021. The patientexperienced a sore left injection site arm) outcome was unknown.            The patient did go see his primary care Physician about this pain and his Physician ordered an x-ray of his left shoulder and neck. The Physician thinks that the patient has a pinched nerve.  Company Comment:  Based on the information provided, causal association between the reported event and the administration of mRNA-1273 cannot be excluded.  Arthralgia and vaccination site pain are consistent with the product known safety profile.   This case was linked to MOD-2021-260346 (Patient Link).; Sender's Comments: Based on the information provided, causal association between the reported event and the administration of mRNA-1273 cannot be excluded.  Arthralgia and vaccination site pain are consistent with the product known safety profile.
The inside of my mouth felt scalded starting about 20 mins post injection.  The roof of my mouth was numb, my tongue felt burned, and my lips were slightly numb.  I had no swelling or airway restriction.  My tongue still feels slightly burned.  I also had terrible heartburn and digestive problems the first 5-7 days.  I am still very fatigued and the injection site is still tender (the injection felt like I was having a marble injected into my arm).
5.6 cm local rxn with tenderness & swelling.  Onset fever 101-102 a few hrs after vaccine admin & persisting x48 hours at time of exam.  No other sign or sx of illness.
Patient waited 15 minutes after injection. Pt felt nausous. Got up to go to bathroom, passed out, landed on face, stomach. Had bloody nose. Had seizure-like activity. Taken to hospital for evaluation.
Pink mark on the same site of the injection; Soreness on his arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pink mark on the same site of the injection) and VACCINATION SITE PAIN (Soreness on his arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness on his arm). On 04-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pink mark on the same site of the injection). At the time of the report, VACCINATION SITE DISCOLOURATION (Pink mark on the same site of the injection) and VACCINATION SITE PAIN (Soreness on his arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Information has been received from a physician concerning a 13 year old white female weighing 81.5 pounds and height of 59.25 inches with no previous medical history who on 27-AUG-2007 was vaccinated SC in the left arm with the second dose of varicella virus vaccine live (Oka/Merck) (Lot # 658177/1012U). On the same date the patient was also vaccinated IM in the left arm with the first dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (lot # AC52B016AA). On 28-AUG-2007 the patient developed red and painful site injection that lasted approximately 48 hours. The patient was treated with ibuprofen and cool compress. Subsequently, the patient recovered. There were no illness at time of vaccination. Additional information has been requested.
At approximately 1200 on 09/29/21 the employee arrived to the clinic. At approximately 1205 the employee was injected with the 2nd dose of Moderna in the left arm. At approximately 1216 the employee reported feeling ?slightly woozy?. At approximately 1217 vital signs were 98.5F, 100%O2, 63 Pulse, 110/82, 12 respirations. At approximately 1220 supervisor was called. Supervisor ordered team to observe the employee longer and to request the employee go home to consult with their personal physician. Strongly encouraged employee to go home and consult with physician. The employee refused to go home stating ?I am able to walk and drive, If I go home now I will be further behind?. At approximately 1230 sitting vitals 99% O2, 54 Pulse, 12 respirations, 110/78. Standing BP 112/80, 66 pulse. No apparent rash or itching was noted, denies breathing difficulties, denies chest pain, denies any medical history. Observed employee until approximately 1235. At this time employee was released back to work. Gait was steady, no difficulties bending over and raising back up. Encouraged employee to call staff if symptoms worsen or don?t improve. Encouraged employee to call 911 immediately if symptoms of anaphylaxis develops. A follow up call will be made between 1500-1600.
I had the Moderna shot Friday (April 9). Now (April 17) just below the vaccine site I have redness and swelling. Yesterday, it was smaller and looked like a rash. Then, throughout the evening, it swelled up and got very firm and warm. It ached through the night into today and is still swollen and warm.
short of breath; Intense headache; tiredness; body aches; This is a spontaneous report from a contactable other healthcare professional (patient). A 47-year-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ELO124), via an unspecified route of administration on 23Dec2020 at 14:30 on Left arm at single dose for COVID-19 immunization in hospital. The patient medical history included Rheumatoid arthritis, lupus. No known allergy, no allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included baricitinib (OLUMIANT), hydroxychloroquine, prednisone. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Intense headache, tiredness, body aches, short of breath on 24Dec2020; events were resulted in: Doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had been tested for COVID-19 on 27Dec2020: Nasal Swab, result was unknown. No treatment was received for the events. The outcome of the events was not recovered.
Red, swollen, warm to touch. Redness was 10cm across at widest point.